预测口腔癌患者的生存率:基于中国SEER数据库和外部验证的研究
Yongmei Tan1,2, Guoxing Huang1,2, Jintao Hu2,3
1Department of Oral and Maxillofacial Surgery, Department of General Dentistry, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Cancer medicine
|January 29, 2024
概括
这项研究开发了准确的诺基图来预测口腔粘膜癌 (BMC) 患者的整体存活率 (OS) 和癌症特异性存活率 (CSS). 这些工具为改善患者结果提供了显著的临床益处.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 生物统计学 生物统计学
背景情况:
- 口腔粘膜癌 (BMC) 是一种普遍存在的口腔恶性瘤,预后通常不佳.
- 准确的生存预测对于有效的患者管理和治疗规划至关重要.
研究的目的:
- 在BMC患者中开发和验证1年,3年和5年的整体存活率 (OS) 和癌症特异性存活率 (CSS) 的预测性名录.
- 评估这些名录的临床实用性和准确性,以预测患者的结果.
主要方法:
- 利用监测流行病学和最终结果 (SEER) 数据库 (2004-2019) 的数据进行初步开发和验证.
- 采用单变量和多变量考克斯回归分析来确定独立的预后预测因素.
- 使用来自孙中山纪念医院 (SYSMH) 的数据进行了外部验证.
主要成果:
- 开发了两种用于OS和CSS预测的诺姆图,实现了高C指数 (例如,培训OS的0.767,培训CSS的0.801,SYSMH OS的0.849,SYSMH CSS的0.916).
- 诺米图表通过ROC曲线,校准曲线和DCA显示出出色的预测准确性和临床意义.
- 外部验证证实了名图的高精度和临床益处,优于TNM分期系统.
结论:
- 开发的诺米图准确地预测BMC患者的短期和长期OS和CSS.
- 预计在临床实践中实施这些名ograms将通过帮助个性化治疗策略,显著有利于BMC患者.
相关概念视频
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Kaplan-Meier Approach
141
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
141
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188


